Corrigendum: Consensus Recommendations for the Diagnosis and Management of X-Linked Hypophosphatemia in Belgium.

Burosumab, fibroblast growth factor 23, osteomalacia, rickets, vitamin D, X-linked hypophosphatemia Keywords: Burosumab; fibroblast growth factor 23; osteomalacia; rickets; vitamin D; X-linked hypophosphatemia EN Burosumab fibroblast growth factor 23 osteomalacia rickets vitamin D X-linked hypophosphatemia 1 2 2 05/27/21 20210525 NES 210525 There is an error in the Conflict of Interest statement. JV has received conference support and consultancy fees from Alexion, Bellco, Ferring, Medtronic, and Kyowa Kirin. [Extracted from the article]